New non-opioid pain medication approved by FDA
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.
Common painkiller used by millions could boost your brain, not just banish your pain, study finds
The painkiller commonly used to relieve headaches, toothache, back pain and cold symptoms, may speed up reaction times, boost ...
Contraceptive device Alyra developed in Adelaide could revolutionise the treatment for period pain
Adelaide researchers have developed a world-first contraceptive device that could revolutionise the treatment for period pain ...
95.3 MNC14h
Indiana tobacco retailers cited for illegal sales of nitrous oxide
You’ve heard of drugs like marijuana, cocaine, and pain medications being used recreationally, but what about…laughing gas? While nitrous oxide has clinical and medicinal purposes – such as sedating ...
Daily Jang15h
FDA approves first novel non-opioid painkiller in decades
The US Food and Drug Administration has approved the first-ever non-opioid pain reliever in more than two decades.According ...
hometownstations17h
FDA approves new non-opioid pain medication
Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid addiction in the United States.
Do you know ginger works as a painkiller for migraine and period cramps? Know how to use it
Ginger acts as a wonderful painkiller, very few people know this, but whenever you have severe pain, you can adopt this as a ...
Knowridge20h
Cannabinoids can be a safer alternative for pain relief
All three cannabinoids reduced the electrical activity linked to Nav1.8, but CBG had the strongest effect. This suggests that CBG could be the most promising candidate for developing new pain ...